Trial Profile
Long-Term Active Surveillance Study for Oral Contraceptives (LASS).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms LASS
- 13 Nov 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 25 Mar 2011 Interim results have been reported in a Bayer Healthcare Pharmaceuticals media release.
- 03 Jun 2008 New trial record.